Morgan Stanley (MS) has been one of the strongest performers among large U.S. financial institutions, and as the stock has climbed, investors have increasingly turned their attention to whether it can reach $250. That figure is not arbitrary: Bank of America, BMO Capital Markets, Keefe, Bruyette & Woods, and DBS have each published $250 price targets for the shares, while Barclays has set a Street-high objective of $262 and UBS holds a $260 target. With the stock trading around $215, reaching $250 would imply roughly 15% upside and a move decisively beyond the current 52-week high of $232.25.
Morgan Stanley is a global financial services holding company founded in 1924 and headquartered in New York. It operates through three segments: Institutional Securities (investment banking and trading), Wealth Management, and Investment Management. The firm held approximately $9.3 trillion in client assets at the end of 2025 and carries a market capitalization of roughly $338 billion, with a price-to-earnings (P/E) ratio of about 17 and a dividend yield near 2.1%.
The company recently raised its quarterly dividend to $1.15 per share and authorized a $20 billion share-buyback program covering up to 5.6% of shares outstanding, signaling management confidence in the firm's earnings power.
The fundamental backdrop has been notably strong. Morgan Stanley has posted four consecutive quarters of revenue and earnings beats, with its latest quarter delivering earnings per share (EPS) of $3.46 against a consensus estimate of $2.89 and revenue of $21.35 billion, up 27% year over year. Institutional Securities revenue rose 44%, reflecting a recovery in dealmaking and trading, while Wealth Management added substantial net new assets.
Morgan Stanley's diversified model is central to the bull case. Wealth and investment management generate recurring, fee-based revenue tied to client assets, providing stability across market cycles, while investment banking and trading offer cyclical upside when capital-markets activity accelerates. Management has also signaled confidence, noting the firm's return on tangible equity (RoTE) has run well above its long-term target of roughly 17.5%.
Wall Street's consensus rating on MS is a "Moderate Buy," with an average 12-month price target that has climbed to roughly $225 to $242 depending on the data source. The highest targets cluster between $250 and $262, meaning the $250 objective sits comfortably within, though near the upper end of, the Street's current expectations. Throughout 2026, most covering firms raised their targets, and Freedom Capital upgraded the stock to Buy while Oppenheimer moved to an Underperform rating in late June — a reminder that conviction is not universal.
From a technical perspective, $250 is a psychological round-number milestone, but the stock must first navigate a nearer obstacle. The 52-week high of $232.25, reached in mid-July, now functions as the principal resistance level that must be cleared on conviction before the shares can extend toward $250. On the downside, the stock has been consolidating near its 50-day moving average around $216, while its 200-day moving average near $198 represents a longer-term support zone. The recent pullback of roughly 8% from the July peak suggests the shares are in a period of digestion after a powerful advance of more than 40% over the past year.
Several risks stand between the current price and $250. First, valuation is no longer cheap: after a roughly 42% one-year gain, the stock trades at elevated levels relative to its own history, and analysts have noted the shares are near multi-year valuation highs. Second, Morgan Stanley's earnings remain sensitive to market conditions — a slowdown in deal activity, trading volumes, or asset growth could stall the momentum that has driven recent beats. Third, regulatory scrutiny remains a recurring theme, including a preliminary Financial Industry Regulatory Authority (FINRA) inquiry into compliance practices at the firm's Budapest operations. Finally, a broader market correction would disproportionately pressure capital-markets-sensitive banks.
For traders looking to monitor whether MS can build toward $250, Tickeron's AI Daily Buy/Sell Signals offer a data-driven complement to fundamental and technical analysis. The product uses artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, keep track of existing positions, and identify shifting market trends more efficiently. Exploring these AI-generated signals can help investors stay informed as conditions evolve.
The $250 target for Morgan Stanley is realistic but by no means assured. The strongest supporting factors are genuine: a diversified earnings mix anchored by a $9.3 trillion wealth-management platform, a resurgent investment-banking cycle, and four straight quarters of beats that have pushed analyst targets steadily higher. However, the stock already sits near record highs with a richer valuation, and clearing the $232.25 52-week high is the immediate technical prerequisite. Investors should monitor quarterly earnings, wealth-management net new assets, capital-markets activity, and any regulatory developments. Ultimately, whether MS reaches $250 will hinge on sustaining current earnings momentum rather than relying on multiple expansion alone.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MS has been closely correlated with GS. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if MS jumps, then GS could also see price increases.